Palisade Bio Reports Phase 1b Crohn’s Disease Results for PALI-2108
A five-patient cohort showed a 47.5% reduction in mean endoscopic disease activity and a 58.8% reduction in mean fecal calprotectin after 14 days.
A five-patient cohort showed a 47.5% reduction in mean endoscopic disease activity and a 58.8% reduction in mean fecal calprotectin after 14 days.